In the latest trading session, Siga Technologies Inc. (SIGA) closed at $5.63, marking a +0.9% move from the previous day.
SIGA Technologies, Inc. (NASDAQ:SIGA ) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Company Participants Diem Nguyen - Chief Executive Officer Dan Luckshire - Executive Vice President an
NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months
The latest trading day saw Siga Technologies Inc. (SIGA) settling at $5.43, representing a +0.74% change from its previous close.
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conferenc
The latest trading day saw Siga Technologies Inc. (SIGA) settling at $6.12, representing a +1.32% change from its previous close.
The latest trading day saw Siga Technologies Inc. (SIGA) settling at $6.04, representing a +0.83% change from its previous close.
In the closing of the recent trading day, Siga Technologies Inc. (SIGA) stood at $6.03, denoting a -0.66% change from the preceding trading day.
The latest trading day saw Siga Technologies Inc. (SIGA) settling at $5.83, representing a +0.87% change from its previous close.
In the closing of the recent trading day, Siga Technologies Inc. (SIGA) stood at $6.34, denoting a -1.71% change from the preceding trading day.
In the most recent trading session, Siga Technologies Inc. (SIGA) closed at $6.47, indicating a +1.25% shift from the previous trading day.
Siga Technologies Inc. (SIGA) closed the most recent trading day at $6.23, moving -0.24% from the previous trading session.
The latest trading day saw Siga Technologies Inc. (SIGA) settling at $6.35, representing a +0.32% change from its previous close.
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, a commercial stage pharmaceutical company, announced today that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE